National blood transfusion and component utilisation trends in Colombia, 2019–2024: A time‐series analysis
Transfusion Medicine · 18.11.2026
DOI: 10.1111/tme.70136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion Medicine, online erschienen am 18.11.2026. Verfasst von Javier Rojas-Marulanda und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objective
To characterise national trends in blood transfusion activity, blood component utilisation, blood supply indicators and regional variability in Colombia between 2019 and 2024, encompassing the pre‐pandemic, pandemic and recovery phases.
Background
Monitoring national transfusion activity provides insight into healthcare system performance and blood‐supply management. While several high‐income countries have reported stable or declining transfusion rates, longitudinal national data from middle‐income settings remain limited. Methods/Materials A retrospective time‐series study was conducted using national blood transfusion surveillance data from Colombia (2019–2024). Annual reports from the Colombian National Institute of Health were analysed to evaluate blood donation activity, blood component utilisation, transfusion practices and regional transfusion rates.
Results
A total of 8 438 003 blood components were transfused across 653 healthcare institutions. National red blood cell (RBC) collection rates increased from 27.2 units per 1000 population in 2019 to 27.9 in 2024. RBC transfusion rates decreased from 18.6 per 1000 inhabitants in 2019 to 15.8 in 2020 and partially recovered to 16.8 in 2024. Buffy coat‐derived platelet utilisation decreased from 14.6% to 10.0%, whereas apheresis platelet and cryoprecipitate utilisation increased from 7.8% to 9.2% and from 5.0% to 6.8%, respectively. Adult intensive care units remained the largest consumers of blood products, accounting for 27%–30% of all transfusions. Regional variability in transfusion rates persisted despite post‐pandemic recovery.
Conclusion
The Colombian blood network demonstrated resilience following the COVID‐19 pandemic. By 2024, blood collection and utilisation had stabilised at levels approaching those observed before the pandemic, suggesting the establishment of a new equilibrium in blood supply and demand.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
ORCID-Profile: Javier Rojas-Marulanda, Sara Rodríguez-González, Santiago Bolívar-Areiza, María-Paula Patiño-Rattiva, Michel-Andrés García-Otálora
Zitieren
APA
Rojas-Marulanda, J., Rodríguez-González, S., Bolívar-Areiza, S., Torres-Pineda, L., Patiño-Rattiva, M. P., & García-Otálora, M. A. (2026). National blood transfusion and component utilisation trends in Colombia, 2019–2024: A time‐series analysis. Transfusion Medicine. https://doi.org/10.1111/tme.70136
Vancouver
Rojas-Marulanda J, Rodríguez-González S, Bolívar-Areiza S, Torres-Pineda L, Patiño-Rattiva MP, García-Otálora MA. National blood transfusion and component utilisation trends in Colombia, 2019–2024: A time‐series analysis. Transfusion Medicine. 2026. doi:10.1111/tme.70136
BibTeX
@article{RojasMarulanda2026,
author = {Rojas-Marulanda, Javier and Rodríguez-González, Sara and Bolívar-Areiza, Santiago and Torres-Pineda, Lauren and Patiño-Rattiva, María-Paula and García-Otálora, Michel-Andrés},
title = {National blood transfusion and component utilisation trends in Colombia, 2019–2024: A time‐series analysis},
journal = {Transfusion Medicine},
year = {2026},
doi = {10.1111/tme.70136}
}
EUVIMED